Impact of surgery versus other treatment options in recurrent glioblastoma. Analysis of the Spanish Group of Neurooncology Research (GEINO) RETSINE database.
Por:
Salgado, M, Lenza, I, Berron, S, Rubio, O, Sarrio, R, Verduguez, M, Sarabia, R, Diaz-Santos, J, Rubio, A, Fernandez, I, Toribio, M, Alvarez, M, Tomas, A, Horno, I, Sanchez, J, Munoz, S, Alvarez-Ballesteros, P and Bataller, R
Publicada:
20 may 2021
Resumen:
Filiaciones:
Ramon & Cajal Univ Hosp, Med Oncol Dept, Madrid, Spain.
Hosp Univ Canarias, Med Oncol, San Cristobal De La L, Spain.
Hosp Univ Josep Trueta, Inst Catala Oncol, Girona, Spain.
Hosp Sant Pau, Barcelona, Spain.
Hosp Univ La Fe, Valencia, Spain.
Hosp Gen Elche, Elche, Spain.
Hosp Rio Ortega, Valladolid, Spain.
Hosp Univ Carlos Haya, Malaga, Spain.
Hosp G Univ Morales Meseguer, Dept Hematol & Med Oncol, IMIB Arrixaca, Murcia, Spain.
Hosp Alvaro Cunqueiro, Vigo, Spain.
Hosp Univ Araba, Vitoria, Spain.
Complejo Hosp Navarra, Pamplona, Spain.
Hosp Gen Univ Valencia, Valencia, Spain.
Hosp Gen Catalunya, Inst Oncol Dr Rosell, Sant Cugat Del Valles, Spain.
HU 12 Octubre, Madrid, Spain.
Hosp Sant Joan Reus, Reus, Spain.
Ramon Y Cajal Univ Hosp, Madrid, Spain.
Hosp Prov Castellon, Castellon De La Plana, Spain.
|